Fig. 1.
Flow chart showing inclusion/exclusion criteria for study participation. The number of measurements (samples) is given, together with the number of individuals/number of families below/in brackets. Treatment* refers to samples excluded (n = 93) because patients were on reverse transcriptase or JAK inhibitors